The landscape of dementia diagnosis has evolved considerably with the appearance of subtle biomarkers, including amyloid PET scans, tau imaging, and blood-based checks that will detect Alzheimer's pathology a long time in advance of signs or symptoms emerge. Though these technological advancements characterize outstanding progress in being familiar with neurodegenerative https://mickq652scm3.newbigblog.com/profile